Summary

Report Scope
The current report provides detailed information on advanced drug delivery systems (ADDS). This report analyzes the market trends of ADDS with data from 2024, estimates for 2025, projections of compound annual growth rates through 2030 (forecast period 2025-2030) and regional markets of advanced drug delivery systems. This report highlights the advanced drug delivery systems’ current and future market potential of ADDS and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities, as well as market projections for 2030 and the market shares of leading manufacturers.
The market is segmented by routes of administration into enteral, parenteral, nasal, transdermal, implant, ophthalmic and other routes. Enteral routes are sub-segmented into oral, sublingual, buccal and rectal. Parenteral routes are sub-segmented into intravenous, subcutaneous and intramuscular. The respiratory route is sub-segmented into intranasal and inhalational.
The market is segmented by technology into targeted-release drug delivery, extended-release drug delivery, delayed-release drug delivery, immediate-release drug delivery and pulsatile-release drug delivery. Based on vehicle/carriers, the market scope is segmented into nanoparticles, monoclonal antibodies, liposomes, polymer therapeutics, prodrugs, microparticles and others.
The market is segmented by application into oncological, cardiovascular, respiratory, autoimmune, inflammatory, metabolic, as well as gastrointestinal disorders, ophthalmic and other therapeutics.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America. The regional segment will include a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, data will be provided for 2024 as the base year, with forecast values for 2025 through 2030.
 

The report aims to:
- Analyze types of ADDS.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts for 2030.
- Assess market shares, competitiveness and industry structure.
- Identify potential long-term impacts on the advanced drug delivery systems market.

Report Includes
- 170 data tables and 79 additional tables
- Overview and an analysis of the global markets and technologies for advanced drug delivery systems (ADDS) with a focus on the routes of administration (RoA)
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the advanced drug delivery systems, accompanied by a market share analysis by route of administration, technology, application, vehicle/carrier and region
- Analysis of current and future demand in the global advanced drug delivery systems market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
- Market share analysis of the key market participants in the advanced drug delivery systems market, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Company profiles of the leading global players, including AbbVie Inc., GSK plc, AstraZeneca, Novartis AG, Roche and Johnson & Johnson Services, Inc.
 

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factors Analysis
Impact of U.S. Tariffs on the Pharmaceutical Industry
Healthcare Expenditure
Aging Population
Geopolitical Risks, Trade Wars and Supply Chain Disruptions
Impact of Global Economic Growth (GDP) on the Pharma Sector
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Chronic Diseases
Nanotechnology in Advancing Drug Delivery
Advances in Therapeutics and Material Science
Increasing R&D Spending by Companies
Rise in Government Funding and Pharmaceutical R&D Spending
Market Restraints
Route-Specific Barriers
Limitations with Nanotechnology and Nanoparticles
Challenges with Nano-drug Delivery
Market Opportunities
Cost-Efficiency of Advanced Drug Delivery Systems
Mechanism of Nanoparticles in Overcoming Drug Resistance
Emerging Markets
Chapter 4 Regulatory Landscape
Overview
The U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
Overview
Artificial Intelligence (AI) and Machine Learning (ML)
3D Printing
Smart Drug Delivery System
Clinical Trial Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Key Takeaways
Patent Analysis
Patents, by Leading Applicant
Patents, by Jurisdiction
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Advanced Drug Delivery Systems, by Route of Administration
Key Takeaways
Enteral Routes
Parenteral Routes
Respiratory Route
Transdermal Route
Implants
Ophthalmic
Others
Global Market for Advanced Drug Delivery Systems, by Technology
Key Takeaways
Targeted Release Drug Delivery
Extended Release Drug Delivery
Delayed Release Drug Delivery
Immediate Release Drug Delivery
Pulsatile Release Drug Delivery
Global Market for Advanced Drug Delivery Systems, by Vehicle/Carrier
Key Takeaways
Nanoparticles
Monoclonal Antibodies
Liposomes
Polymer Therapeutics
Prodrugs
Microparticles
Other Vehicles/Carriers
Global Market for Advanced Drug Delivery Systems, by Application
Key Takeaways
Oncology
Cardiovascular Diseases
Respiratory Diseases
Autoimmune Diseases
Inflammatory Diseases
Metabolic Diseases
Gastrointestinal Disorders
Ophthalmic
Other Applications
Geographic Breakdown
Global Market for Advanced Drug Delivery Systems, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Sustainability in the Advanced Drug Delivery Systems Market: An ESG Perspective
Introduction to ESG
Sustainability in the Advanced Drug Delivery Systems Market
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABBOTT
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BAXTER
BAYER AG
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
GSK PLC
JAZZ PHARMACEUTICALS INC.
JOHNSON & JOHNSON
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SANOFI
Emerging Companies in the Advanced Drug Delivery Systems Market

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Advanced Drug Delivery Systems, by Region, Through 2030
Table 1 : Current Health Expenditure, by Country, 2021-2023
Table 2 : Rheumatoid Arthritis - Level 3 Cause, 2021
Table 3 : Global HIV Epidemic, by Age Group, 2023
Table 4 : Global Diabetes Prevalence, Estimates and Projections, 2024–2050
Table 5 : National Cancer Institute Funding, by Mechanism, 2020-2024
Table 6 : Research Projects Using 3D Printing Techniques to Design Drug Delivery Systems
Table 7 : Clinical Trials in Advanced Drug Delivery Systems, by Type of Study, as of September 2025
Table 8 : ADDS Clinical Trials, by Status, as of September 2025
Table 9 : ADDS Clinical Trials, by Phase, as of September 2025
Table 10 : List of Phase IV ADDS Clinical Trials, 2025
Table 11 : Patents Granted for Drug Delivery Systems, by Leading Applicant, 2025
Table 12 : Patents Granted for Drug Delivery Systems, by Jurisdiction, 2025
Table 13 : Global Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 14 : Global Market for Enteral Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 15 : Global Market for Enteral Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 16 : Oral Route: Market Overview
Table 17 : Sublingual and Buccal Route: Market Overview
Table 18 : Examples of Clinically Approved Rectal Formulations
Table 19 : Rectal Route: Market Overview
Table 20 : Vaginal Route: Market Overview
Table 21 : Urethral Route: Market Overview
Table 22 : Parenteral Routes: Market Overview
Table 23 : Global Market for Parenteral Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 24 : Global Market for Parenteral Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 25 : Intravenous Routes: Market Overview
Table 26 : Subcutaneous Routes: Market Overview
Table 27 : Intramuscular Routes: Market Overview
Table 28 : Examples of Specialized Parenteral Routes of Administration
Table 29 : Respiratory Route: Market Overview
Table 30 : Global Market for Respiratory Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 31 : Global Market for Respiratory Routes in Advanced Drug Delivery Systems, by Type, Through 2030
Table 32 : Intranasal Route: Market Overview
Table 33 : Inhalational Route: Market Overview
Table 34 : Transdermal Route: Market Overview
Table 35 : Global Market for Transdermal Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 36 : Global Market for Implants in Advanced Drug Delivery Systems, by Region, Through 2030
Table 37 : Examples of Ophthalmology Drug Delivery Systems
Table 38 : Global Market for Ophthalmic Route in Advanced Drug Delivery Systems, by Region, Through 2030
Table 39 : Global Market for Other Routes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 40 : Global Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 41 : Examples of Delivery Carriers for Targeted Drug Delivery Systems
Table 42 : Global Market for Targeted Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 43 : Sustained vs. Controlled Drug Delivery
Table 44 : Global Market for Extended Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 45 : Global Market for Delayed Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 46 : Global Market for Immediate Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 47 : Global Market for Pulsatile Release Drug Delivery in Advanced Drug Delivery Systems, by Region, Through 2030
Table 48 : Global Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 49 : Examples of Nanocarriers in Drug Delivery and Their Characteristics
Table 50 : Global Market for Nanoparticles in Advanced Drug Delivery Systems, by Region, Through 2030
Table 51 : Global Market for Monoclonal Antibodies in Advanced Drug Delivery Systems, by Region, Through 2030
Table 52 : Global Market for Liposomes in Advanced Drug Delivery Systems, by Region, Through 2030
Table 53 : Global Market for Polymer Therapeutics in Advanced Drug Delivery Systems, by Region, Through 2030
Table 54 : Global Market for Polymer Therapeutics in Advanced Drug Delivery Systems, by Type, Through 2030
Table 55 : Global Market for Prodrugs in Advanced Drug Delivery Systems, by Region, Through 2030
Table 56 : Global Market for Microparticles in Advanced Drug Delivery Systems, by Region, Through 2030
Table 57 : Global Market for Other Vehicle/Carriers in Advanced Drug Delivery Systems, by Region, Through 2030
Table 58 : Global Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 59 : Global Market for Advanced Drug Delivery System in Oncology, by Region, Through 2030
Table 60 : Examples of Systems Used in the Cardiovascular Delivery of Therapeutics
Table 61 : Global Market for Advanced Drug Delivery Systems in Cardiovascular Diseases, by Region, Through 2030
Table 62 : Global Market for Advanced Drug Delivery Systems in Respiratory Diseases, by Region, Through 2030
Table 63 : Global Market for Advanced Drug Delivery Systems in Autoimmune Diseases, by Region, Through 2030
Table 64 : Global Market for Advanced Drug Delivery Systems in Inflammatory Diseases, by Region, Through 2030
Table 65 : Global Market for Advanced Drug Delivery Systems in Metabolic Diseases, by Region, Through 2030
Table 66 : Global Market for Advanced Drug Delivery Systems in Gastrointestinal Disorders, by Region, Through 2030
Table 67 : Global Market for Advanced Drug Delivery Systems in Ophthalmic Applications, by Region, Through 2030
Table 68 : Global Market for Advanced Drug Delivery Systems in Other Diseases, by Region, Through 2030
Table 69 : Global Market for Advanced Drug Delivery Systems, by Region, Through 2030
Table 70 : North American Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 71 : North American Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 72 : North American Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 73 : North American Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 74 : North American Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 75 : U.S. Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 76 : U.S. Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 77 : U.S. Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 78 : U.S. Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 79 : Canadian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 80 : Canadian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 81 : Canadian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 82 : Canadian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 83 : Mexican Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 84 : Mexican Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 85 : Mexican Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 86 : Mexican Market for Advanced Drug Delivery System, by Application, Through 2030
Table 87 : European Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 88 : European Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 89 : European Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 90 : European Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 91 : European Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 92 : German Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 93 : German Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 94 : German Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 95 : German Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 96 : U.K. Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 97 : U.K. Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 98 : U.K. Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 99 : U.K. Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 100 : French Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 101 : French Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 102 : French Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 103 : French Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 104 : Italian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 105 : Italian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 106 : Italian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 107 : Italian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 108 : Spanish Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 109 : Spanish Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 110 : Spanish Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 111 : Spanish Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 112 : Rest of Europe Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 113 : Rest of Europe Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 114 : Rest of Europe Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 115 : Rest of Europe Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 116 : Asia-Pacific Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 117 : Asia-Pacific Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 118 : Asia-Pacific Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 119 : Asia-Pacific Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 120 : Asia-Pacific Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 121 : Chinese Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 122 : Chinese Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 123 : Chinese Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 124 : Chinese Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 125 : Japanese Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 126 : Japanese Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 127 : Japanese Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 128 : Japanese Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 129 : Indian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 130 : Indian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 131 : Indian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 132 : Indian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 133 : South Korean Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 134 : South Korean Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 135 : South Korean Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 136 : South Korean Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 137 : Australian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 138 : Australian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 139 : Australian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 140 : Australian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 141 : Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 142 : Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 143 : Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 144 : Rest of Asia-Pacific Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 145 : MEA Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 146 : MEA Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 147 : MEA Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 148 : MEA Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 149 : MEA Market for Advanced Drug Delivery Systems, by Sub-Region, Through 2030
Table 150 : Middle East Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 151 : Middle East Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 152 : Middle East Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 153 : Middle East Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 154 : African Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 155 : African Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 156 : African Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 157 : African Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 158 : South American Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 159 : South American Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 160 : South American Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 161 : South American Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 162 : South American Market for Advanced Drug Delivery Systems, by Country, Through 2030
Table 163 : Brazilian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 164 : Brazilian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 165 : Brazilian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 166 : Brazilian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 167 : Argentinian Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 168 : Argentinian Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 169 : Argentinian Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 170 : Argentinian Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 171 : Rest of South America Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2030
Table 172 : Rest of South America Market for Advanced Drug Delivery Systems, by Technology, Through 2030
Table 173 : Rest of South America Market for Advanced Drug Delivery Systems, by Vehicle/Carrier, Through 2030
Table 174 : Rest of South America Market for Advanced Drug Delivery Systems, by Application, Through 2030
Table 175 : Key Strategic Initiatives in the Advanced Drug Delivery Systems Market, 2024–2025
Table 176 : Key Focus Areas in ESG Metrics
Table 177 : ESG Rankings for Leading Companies in the Advanced Drug Delivery Systems Market, 2025*
Table 178 : Abbreviations Used in this Report
Table 179 : Information Sources for This Report
Table 180 : Abbott: Company Snapshot
Table 181 : Abbott: Financial Performance, FY 2023 and 2024
Table 182 : Abbott: Product Portfolio
Table 183 : Abbott: News/Key Developments, 2024
Table 184 : AbbVie Inc.: Company Snapshot
Table 185 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
Table 186 : AbbVie Inc.: Product Portfolio
Table 187 : AbbVie Inc.: News/Key Developments, 2023-2025
Table 188 : Amgen Inc.: Company Snapshot
Table 189 : Amgen Inc.: Financial Performance, FY 2023 and 2024
Table 190 : Amgen Inc.: Product Portfolio
Table 191 : Amgen Inc.: News/Key Developments, 2022–2023
Table 192 : AstraZeneca: Company Snapshot
Table 193 : AstraZeneca: Financial Performance, FY 2023 and 2024
Table 194 : AstraZeneca: Product Portfolio
Table 195 : AstraZeneca: News/Recent Developments, 2023–2025
Table 196 : Baxter: Company Snapshot
Table 197 : Baxter: Financial Performance, FY 2023 and 2024
Table 198 : Baxter: Product Portfolio
Table 199 : Baxter: News/Key Developments, 2021
Table 200 : Bayer AG: Company Snapshot
Table 201 : Bayer AG: Financial Performance, FY 2023 and 2024
Table 202 : Bayer AG: Product Portfolio
Table 203 : Bayer AG: News/Key Developments, 2022
Table 204 : Boston Scientific Corp.: Company Snapshot
Table 205 : Boston Scientific Corp.: Financial Performance, FY 2023 and 2024
Table 206 : Boston Scientific Corp.: Product Portfolio
Table 207 : Boston Scientific Corp.: News/Key Developments, 2024–2025
Table 208 : Bristol-Myers Squibb Co.: Company Snapshot
Table 209 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2024
Table 210 : Bristol-Myers Squibb Co.: Product Portfolio
Table 211 : Bristol-Myers Squibb Co.: News/Key Developments, 2023–2025
Table 212 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 213 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 214 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 215 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023–2025
Table 216 : Gilead Sciences Inc.: Company Snapshot
Table 217 : Gilead Sciences Inc.: Financial Performance, FY 2023 and 2024
Table 218 : Gilead Sciences Inc.: Product Portfolio
Table 219 : Gilead Sciences Inc.: News/Key Developments, 2023–2025
Table 220 : GSK plc: Company Snapshot
Table 221 : GSK plc: Financial Performance, FY 2023 and 2024
Table 222 : GSK plc: Product Portfolio
Table 223 : GSK plc: News/Key Developments, 2022–2025
Table 224 : Jazz Pharmaceuticals Inc.: Company Snapshot
Table 225 : Jazz Pharmaceuticals Inc.: Financial Performance, FY 2023 and 2024
Table 226 : Jazz Pharmaceuticals Inc.: Product Portfolio
Table 227 : Jazz Pharmaceuticals Inc.: News/Key Developments, 2024–2025
Table 228 : Johnson & Johnson: Company Snapshot
Table 229 : Johnson & Johnson: Financial Performance, FY 2023 and 2024
Table 230 : Johnson & Johnson Services Inc.: Product Portfolio
Table 231 : Johnson & Johnson: News/Key Developments, 2022−2025
Table 232 : Merck & Co. Inc.: Company Snapshot
Table 233 : Merck & Co. Inc.: Financial Performance, FY 2023 and 2024
Table 234 : Merck & Co. Inc.: Product Portfolio
Table 235 : Merck & Co. Inc.: News/Key Developments, 2025
Table 236 : Novartis AG: Company Snapshot
Table 237 : Novartis AG: Financial Performance, FY 2023 and 2024
Table 238 : Novartis AG: Product Portfolio
Table 239 : Novartis AG: News/Key Developments, 2022–2025
Table 240 : Pfizer Inc.: Company Snapshot
Table 241 : Pfizer Inc.: Financial Performance, FY 2023 and 2024
Table 242 : Pfizer Inc.: Product Portfolio
Table 243 : Pfizer Inc.: News/Key Developments, 2023–2025
Table 244 : Sanofi: Company Snapshot
Table 245 : Sanofi: Financial Performance, FY 2023 and 2024
Table 246 : Sanofi: Product Portfolio
Table 247 : Sanofi: News/Key Developments, 2022–2024
Table 248 : A Few Emerging Companies in the Advanced Drug Delivery Systems Market